ConductScience.org, home

Paper64800

Intensive plasma exchange and renal-transplant rejection.

Cardella CJ and 3 others. Lancet, 1977. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Intensive plasma exchange and renal-transplant rejection. Papers, record 64800. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/64800

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intensive plasma exchange and renal-transplant rejection.
PubMed
Journal
Lancet
PubMed
Year
1977
PubMed
Publication types
Letter
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cardella CJC J
2Sutton DD
3Uldall PRP R
4deVeber GAG A

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Graft RejectionMajor topic
Kidney TransplantationMajor topic
PlasmapheresisMajor topic
Adrenal Cortex Hormones
Antilymphocyte Serum
Creatinine
Cyclophosphamide
Humans
Serum Globulins
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
37568328Current Therapies in Kidney Transplant Rejection.J Clin Med2023https://conductscience.org/library/papers/37568328PubMed
35723077Therapeutic apheresis in kidney diseases: an updated review.Ren Fail2022https://conductscience.org/library/papers/35723077PubMed
33806743Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation.J Clin Med2021https://conductscience.org/library/papers/33806743PubMed
25986911Role of therapeutic plasmapheresis in ANCA-associated vasculitis.Pediatr Nephrol2016https://conductscience.org/library/papers/25986911PubMed
7008987Extracorporeal immunoadsorption of myeloma IgG and autoimmune antibodies: a clinically feasible modality of treatment.Clin Exp Immunol1980https://conductscience.org/library/papers/7008987PubMed
2178759Plasma exchange in Canada. The Canadian Apheresis Study Group.CMAJ1990https://conductscience.org/library/papers/2178759PubMed
101289Plasma exchange and plasmapheresis.Can Med Assoc J1978https://conductscience.org/library/papers/101289PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/64800

GET https://conductscience.org/api/papers/v1/64800/authors